{"id":"W4405038423","doi":"10.1182/blood-2024-200937","title":"Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) for Second-Line (2L) Treatment of Patients (pts) with Refractory/Early Relapsed (R/R) Large B-Cell Lymphoma (LBCL): Update with 34 Months of Liso-Cel Follow-up","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Refractory (planetary science); Medicine; Internal medicine; Second line treatment; Nuclear medicine; Gastroenterology; Oncology; Physics; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006467343,0.001282861,0.002779147,0.0005986017,0.0002012341,0.0008242017,0.0008839349,0.0009017092,0.004934067],"category_scores_gemma":[0.01057988,0.0003471727,0.006960083,0.0004692661,0.0004781008,0.0008517409,0.0008871856,0.002098766,0.0003640818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007945172,"about_ca_system_score_gemma":0.0006310747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001296454,"about_ca_topic_score_gemma":0.002361744,"domain_scores_codex":[0.9945773,0.003779578,0.0003539333,0.000683469,0.0003769515,0.0002288218],"domain_scores_gemma":[0.9964394,0.002114397,0.0007334911,0.0004129196,0.0001333416,0.0001663113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.8084015,0.0007557738,0.01527894,0.003928644,0.1210035,0.000107536,0.0001347976,0.002904308,0.002160035,0.00100786,0.002025646,0.04229147],"study_design_scores_gemma":[0.3971506,0.1748365,0.1122539,0.0009663633,0.2665882,0.0004634781,0.0002528701,0.02007087,0.006333358,0.00492795,0.01598298,0.0001728905],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9532318,0.02329447,0.008498666,0.000532028,0.001252087,0.002506593,0.006409816,0.0002224919,0.004052115],"genre_scores_gemma":[0.9907836,0.001074955,0.002944577,0.0005054342,0.0001515075,0.001526588,0.001725629,0.00003198774,0.001255799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006467343,"threshold_uncertainty_score":0.03420299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02732673755929444,"score_gpt":0.2813193888939903,"score_spread":0.2539926513346959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}